Publication | Open Access
Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
544
Citations
18
References
2021
Year
ClinicalTrials.gov Identifiers: NCT02484547, NCT02477800.
| Year | Citations | |
|---|---|---|
Page 1
Page 1